Bioxcel Therapeutics shares owned by Tocqueville Asset Management
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Tocqueville Asset Management
from 13F filings
Historical chart of Tocqueville Asset Management investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Tocqueville Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Tocqueville Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $148k | 50k | 2.95 |
| 2023-09-30 | $100k | 40k | 2.53 |
| 2023-06-30 | $264k | 40k | 6.66 |
| 2023-03-31 | $690k | 37k | 18.66 |
| 2022-12-31 | $846k | 39k | 21.48 |
| 2022-09-30 | $339k | 29k | 11.83 |
| 2022-06-30 | $415k | 32k | 13.20 |
| 2022-03-31 | $391k | 19k | 20.91 |
| 2021-12-31 | $354k | 17k | 20.34 |
| 2021-09-30 | $552k | 18k | 30.33 |
| 2021-06-30 | $572k | 20k | 29.04 |
| 2021-03-31 | $628k | 15k | 43.16 |
| 2020-12-31 | $236k | 5.1k | 46.27 |
| 2020-09-30 | $204k | 4.7k | 43.40 |
More positions owned by Tocqueville Asset Management
Home Depot (HD)
View all positions for Tocqueville Asset Management